Vol.

No.

December 04, 2020Dec 04, 2020

DOWNLOAD THE PDF

Cover Story

Federate the data: NCI produces master plan for the Childhood Cancer Data Initiative

By Matthew Bin Han Ong

NCI is using a hub-and-spoke structure to engineer an ambitious data federation for pediatric cancers—which, if done right, is anticipated to become the gold standard for a new generation of comprehensive cancer databases.

NCI Director's Report

Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.”

By Alexandria Carolan

Cancer groups say Trump administration's drug pricing rule will likely harm patients

By Paul Goldberg

Clinical Free Trials & Tribulations

How AI uncovers “invisible” socioeconomic risk factors to improve cancer care

By Amy Valley

In Brief

GRAIL and UK government plan to make Galleri multi-cancer early detection blood test available

Raymond Bergan named deputy director at Fred & Pamela Buffett Cancer Center

Ramsay Camp named chief of surgical oncology at Baylor College of Medicine

IU's Harikrishna Nakshatri receives $1.3 million to improve breast cancer treatment for Black women

FDA and AACR collaborate on Project Livin' Label

Ohio State creates Clara D. Bloomfield Center for leukemia outcomes research

Funding Opportunities

Israel Cancer Research Fund offers 69 cancer research grants

Clinical Roundup

UVA researchers identify gene responsible for metastasis of TNBC

City of Hope initiates phase I study to test its first SARS-CoV-2 investigational vaccine

Drugs & Targets

Danyelza receives FDA approval for treatment of neuroblastoma

Gavreto receives FDA approval for RET-altered thyroid cancers

FDA approves first PSMA-targeted PET imaging drug for in prostate cancer

European Commission approves Opdivo as second-line treatment for unresectable advanced, recurrent or metastatic ESCC

EMA validates tepotinib application for treatment of advanced NSCLC with METex14 skipping alterations

NCI Trials

NCI Trials for December 2020

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues